Showing results (551-560 of 617) with videos related to

Sort By:
Pageof 62
American Journal of Obstetrics and Gynecology|February 18, 2011
Prospective evaluation of insulin resistance among endometrial cancer patientsJennifer K Burzawa, Kathleen M Schmeler, Pamela T Soliman, et al.
Cancer|November 11, 2011
Reclassification of serous ovarian carcinoma by a 2-tier system: a Gynecologic Oncology Group StudyDiane C Bodurka, Michael T Deavers, Chunqiao Tian, et al.
Molecular Cancer Therapeutics|October 5, 2010
Targeting aldehyde dehydrogenase cancer stem cells in ovarian cancerCharles N Landen, Blake Goodman, Ashwini A Katre, et al.
Cancer Prevention Research (Philadelphia, Pa.)|May 4, 2013
Prospective multicenter randomized intermediate biomarker study of oral contraceptive versus depo-provera for prevention of endometrial cancer in women with Lynch syndromeKaren H Lu, David S Loose, Melinda S Yates, et al.
American Journal of Obstetrics and Gynecology|April 9, 2008
Impact of vessel maturation on antiangiogenic therapy in ovarian cancerChunhua Lu, Premal H Thaker, Yvonne G Lin, et al.
Cancer Research|November 17, 2005
Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovaryTomas Bonome, Ji-Young Lee, Dong-Choon Park, et al.
Gynecologic Oncology|August 25, 2001
High-dose topotecan, melphalan, and cyclophosphamide (TMC) with stem cell support: a new regimen for the treatment of advanced ovarian cancerM L Donato, D M Gershenson, J T Wharton, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|June 4, 2008
HLA class I antigen processing machinery component expression and intratumoral T-Cell infiltrate as independent prognostic markers in ovarian carcinomaLiz Y Han, Mavis S Fletcher, Diana L Urbauer, et al.
Cancer Research|December 9, 2024
Gain-of-Function Chromatin Remodeling Activity of Oncogenic FOXL2C134W Reprograms Glucocorticoid Receptor Occupancy to Drive Granulosa Cell TumorsThomas Welte, Veena K Vuttaradhi, Eleonora Y Khlebus, et al.
Gynecologic Oncology|August 31, 2025
Efficacy of cyclin-dependent kinase 4/6 inhibitors in preclinical adult-type ovarian granulosa cell tumor modelsAllison L Brodsky, Thomas Welte, Veena K Vuttaradhi, et al.
Pageof 62